Menu Search
Equities

Altria Group Inc

PHM7:HAN

Altria Group Inc

Actions
  • Price (EUR)42.29
  • Today's Change0.23 / 0.55%
  • Shares traded185.00
  • 1 Year change-8.41%
  • Beta--
Data delayed at least 15 minutes, as of Jun 09 2023 12:11 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Altria Group, Inc. is a holding company that provides a portfolio of tobacco products for United States tobacco consumers aged 21+. The Company operates through two segments: smokeable tobacco products and oral tobacco products. The smokeable tobacco products consist of combustible cigarettes manufactured and sold by Philip Morris USA Inc. (PM USA ), and machine-made large cigars and pipe tobacco manufactured and sold by John Middleton Co. (Middleton). The oral tobacco products consist of moist smokeless tobacco (MST) and snus products manufactured and sold by U.S. Smokeless Tobacco Company LLC (USSTC), and oral nicotine pouches manufactured and sold by Helix Innovations LLC (Helix). The Company’s e-vapor products are marketed by NJOY, LLC (NJOY), a wholly owned subsidiary of the Company. The Company’s brand portfolio of its tobacco operating companies include Marlboro, Black & Mild, Copenhagen, Skoal, on! and NJOY ACE.

  • Revenue in USD (TTM)24.92bn
  • Net income in USD5.58bn
  • Incorporated2009
  • Employees6.30k
  • Location
    Altria Group Inc6601 W Broad StRICHMOND 23230United StatesUSA
  • Phone+1 (804) 274-2200
  • Websitehttps://www.altria.com/
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status		MO:NYQ since
announced		Transaction
value
NJOY Holdings IncDeal completed06 Mar 202306 Mar 2023Deal completed-2.82%3.25bn
Data delayed at least 15 minutes, as of Jun 09 2023 21:10 BST.
An LSEG Business
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.